FIRST HEARTLAND CONSULTANTS, INC. – Gilead Sciences, Inc. Transaction History
FIRST HEARTLAND CONSULTANTS, INC. portfolio value:
$486,000
portfolio value
FIRST HEARTLAND CONSULTANTS, INC. quarter portfolio value change:
-0.19%
quarter
Gilead Sciences, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -12.87% | -1.16K shares | -73K | $61.69 | 7.89K |
Q2 2022 | share | Increase | +16.10% | 1.25K shares | 96K | $61.81 | 9.05K |
Q1 2022 | share | Increase | +7.67% | 556 shares | -63K | $59.45 | 7.80K |
Q4 2021 | share | Decrease | -4.06% | -307 shares | -2K | $73.36 | 7.24K |
Q3 2021 | share | Increase | +17.57% | 1.12K shares | 86K | $69.85 | 7.55K |
Q2 2021 | share | Increase | +41.99% | 1.9K shares | 150K | $68.17 | 6.42K |
Q1 2021 | share | Increase | +15.94% | 622 shares | 65K | $63.33 | 4.52K |
Q4 2020 | share | Decrease | -2.13% | -85 shares | -25K | $56.43 | 3.90K |
Q3 2020 | share | Increase | +13.75% | 482 shares | -18K | $60.52 | 3.98K |
Q2 2020 | share | Decrease | -5.98% | -223 shares | -9K | $72.94 | 3.50K |
Q1 2020 | share | Increase | 0.00% | 3.72K shares | 279K | $70.22 | 3.72K |
Q2 2018 | share | Decrease | -100.00% | -3.04K shares | -230K | $62.43 | 0 |
Q1 2018 | share | Decrease | -0.10% | -3 shares | 12K | $65.91 | 3.04K |
Q4 2017 | share | Decrease | -65.85% | -5.87K shares | -505K | $62.19 | 3.04K |
Q3 2017 | share | 0.00% | 0 shares | 91K | $69.84 | 8.92K | |
Q2 2017 | share | Increase | +0.44% | 39 shares | 28K | $60.63 | 8.92K |
Q1 2017 | share | Decrease | -35.58% | -4.91K shares | -384K | $57.72 | 8.88K |
Q4 2016 | share | Decrease | -29.48% | -5.76K shares | -560K | $60.39 | 13.79K |
Q3 2016 | share | Increase | +32.90% | 4.84K shares | 320K | $66.31 | 19.56K |
Q2 2016 | share | Decrease | -46.74% | -12.92K shares | -1.31M | $69.49 | 14.72K |
Q1 2016 | share | Decrease | -6.85% | -2.03K shares | -464K | $76.1 | 27.64K |